Waters Corporation (WAT)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $90.45B
Last updated: Nov 17, 2026 at 11:05 AM ET
Waters Corporation (WAT) Earnings: Report Dates and Results
Waters (WAT) is expected to report earnings on Feb 8, 2027. In the quarter ended Sep 30, 2026, Waters reported EPS of $4.10, above the $3.99 estimate. It beat the EPS estimate in each of the last 14 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
WAT has an expected report date of Feb 8, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 4.0% above the $4.53 reported for the quarter ended Dec 31, 2025.
WAT Earnings Call
The latest WAT earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, WAT beat 36, missed 3 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $1.77B, up 121.2% from $800.00M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $4.10 | $3.99 | $3.92 - $4.03 | +2.76% | Beat | +20.6% | 20 | 1 up, 0 down | Nov 3, 2026 | $1.77B |
| Jun 30, 2026 | $3.05 | $3.01 | $2.98 - $3.04 | +1.33% | Beat | +3.4% | 20 | N/A | Aug 4, 2026 | $1.65B |
| Mar 31, 2026 | $2.70 | $2.31 | $2.27 - $2.35 | +16.88% | Beat | +20.0% | 18 | 4 up, 4 down | May 5, 2026 | $1.27B |
| Dec 31, 2025 | $4.53 | $4.51 | $4.45 - $4.55 | +0.44% | Beat | +10.5% | 17 | 1 up, 1 down | Feb 9, 2026 | $932.36M |
| Sep 30, 2025 | $3.40 | $3.22 | $3.17 - $3.23 | +5.59% | Beat | +16.0% | 12 | 1 up, 1 down | Nov 4, 2025 | $800.00M |
| Jun 30, 2025 | $2.95 | $2.94 | $2.88 - $3.10 | +0.34% | Beat | +12.2% | 15 | 3 up, 0 down | Aug 4, 2025 | $771.00M |
| Mar 31, 2025 | $2.25 | $2.22 | $2.17 - $2.26 | +1.35% | Beat | +1.8% | 18 | 3 up, 2 down | May 6, 2025 | $662.00M |
| Dec 31, 2024 | $4.10 | $4.03 | $3.99 - $4.10 | +1.74% | Beat | +13.3% | 18 | 1 up, 0 down | Feb 12, 2025 | $872.71M |
| Sep 30, 2024 | $2.93 | $2.68 | $2.64 - $2.73 | +9.33% | Beat | +3.2% | 18 | 2 up, 0 down | Nov 1, 2024 | $740.30M |
| Jun 30, 2024 | $2.63 | $2.56 | $2.50 - $2.60 | +2.73% | Beat | -6.1% | 17 | 1 up, 0 down | Jul 31, 2024 | $708.53M |
| Mar 31, 2024 | $2.21 | $2.09 | $2.05 - $2.14 | +5.74% | Beat | -11.2% | 16 | 4 up, 0 down | May 7, 2024 | $636.84M |
| Dec 31, 2023 | $3.62 | $3.55 | $3.48 - $3.60 | +1.97% | Beat | -5.7% | 17 | 0 up, 0 down | Feb 6, 2024 | $819.47M |
| Sep 30, 2023 | $2.84 | $2.55 | $2.47 - $2.62 | +11.37% | Beat | +7.6% | 16 | 1 up, 1 down | Nov 7, 2023 | $711.69M |
| Jun 30, 2023 | $2.80 | $2.59 | $2.52 - $2.74 | +8.11% | Beat | +1.8% | 16 | 1 up, 0 down | Aug 2, 2023 | $740.58M |
| Mar 31, 2023 | $2.49 | $2.62 | $2.43 - $2.66 | -4.96% | Miss | -11.1% | 17 | 1 up, 0 down | May 9, 2023 | $684.67M |
| Dec 31, 2022 | $3.84 | $3.74 | $3.67 - $3.77 | +2.67% | Beat | +4.6% | 17 | 1 up, 0 down | Feb 15, 2023 | $858.51M |
| Sep 30, 2022 | $2.64 | $2.58 | $2.53 - $2.67 | +2.33% | Beat | -0.8% | 16 | 1 up, 0 down | Nov 1, 2022 | $708.55M |
| Jun 30, 2022 | $2.75 | $2.67 | $2.60 - $2.76 | +3.00% | Beat | +5.8% | 14 | 3 up, 0 down | Aug 2, 2022 | $714.32M |
| Mar 31, 2022 | $2.80 | $2.34 | $2.26 - $2.40 | +19.66% | Beat | +22.3% | 12 | 1 up, 0 down | May 3, 2022 | $690.57M |
| Dec 31, 2021 | $3.67 | $3.49 | $3.42 - $3.56 | +5.16% | Beat | +0.5% | 12 | 0 up, 0 down | Feb 1, 2022 | $836.45M |
| Sep 30, 2021 | $2.66 | $2.36 | $2.27 - $2.54 | +12.71% | Beat | +23.1% | 14 | 0 up, 0 down | Nov 2, 2021 | $659.23M |
| Jun 30, 2021 | $2.60 | $2.28 | $2.15 - $2.35 | +14.04% | Beat | +23.8% | 13 | N/A | Aug 3, 2021 | $681.65M |
| Mar 31, 2021 | $2.29 | $1.57 | $1.51 - $1.62 | +45.86% | Beat | +99.1% | 15 | N/A | May 5, 2021 | $608.54M |
| Dec 31, 2020 | $3.65 | $2.90 | $2.63 - $3.24 | +25.86% | Beat | +14.1% | 17 | N/A | Feb 2, 2021 | $192.87M |
| Sep 30, 2020 | $2.16 | $1.92 | $1.71 - $2.15 | +12.50% | Beat | +1.4% | 15 | N/A | Oct 27, 2020 | $1.19B |
| Jun 30, 2020 | $2.10 | $1.56 | $1.32 - $1.85 | +34.62% | Beat | -1.9% | 14 | N/A | Jul 28, 2020 | $519.98M |
| Mar 31, 2020 | $1.15 | $1.44 | $1.03 - $1.61 | -20.14% | Miss | -28.1% | 15 | N/A | Apr 28, 2020 | $464.94M |
| Dec 31, 2019 | $3.20 | $3.01 | $2.92 - $3.10 | +6.31% | Beat | +11.5% | 16 | N/A | Feb 4, 2020 | $716.29M |
| Sep 30, 2019 | $2.13 | $2.13 | $2.10 - $2.15 | 0.00% | In line | +10.9% | 13 | N/A | Oct 29, 2019 | $577.28M |
| Jun 30, 2019 | $2.14 | $2.11 | $2.09 - $2.15 | +1.42% | Beat | +9.7% | 15 | N/A | Jul 30, 2019 | $599.16M |
| Mar 31, 2019 | $1.60 | $1.73 | $1.69 - $1.77 | -7.51% | Miss | +0.6% | 14 | N/A | Apr 23, 2019 | $513.86M |
| Dec 31, 2018 | $2.87 | $2.64 | $2.59 - $2.77 | +8.71% | Beat | +14.3% | 16 | N/A | Jan 23, 2019 | $715.02M |
| Sep 30, 2018 | $1.92 | $1.90 | $1.87 - $1.95 | +1.05% | Beat | +8.5% | 15 | N/A | Oct 23, 2018 | $578.02M |
| Jun 30, 2018 | $1.95 | $1.92 | $1.87 - $1.98 | +1.56% | Beat | +10.8% | 15 | N/A | Jul 24, 2018 | $596.22M |
| Mar 31, 2018 | $1.59 | $1.55 | $1.52 - $1.62 | +2.58% | Beat | +8.9% | 15 | N/A | Apr 24, 2018 | $530.67M |
| Dec 31, 2017 | $2.51 | $2.45 | $2.41 - $2.48 | +2.45% | Beat | +13.6% | 15 | N/A | Jan 23, 2018 | $687.27M |
| Sep 30, 2017 | $1.77 | $1.75 | $1.72 - $1.77 | +1.14% | Beat | +12.7% | 14 | N/A | Oct 24, 2017 | $565.58M |
| Jun 30, 2017 | $1.76 | $1.71 | $1.66 - $1.75 | +2.92% | Beat | +11.4% | 16 | N/A | Jul 25, 2017 | $558.25M |
| Mar 31, 2017 | $1.46 | $1.34 | N/A | +8.96% | Beat | +15.9% | N/A | N/A | Apr 25, 2017 | $497.97M |
| Dec 31, 2016 | $2.21 | $2.13 | N/A | +3.76% | Beat | +12.8% | N/A | N/A | Jan 24, 2017 | $628.79M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $13.13, up 10.6% from the year before. It was $6.62 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $13.13 | +10.6% |
| Dec 31, 2024 | $11.87 | +1.0% |
| Dec 31, 2023 | $11.75 | -2.3% |
| Dec 31, 2022 | $12.03 | +7.2% |
| Dec 31, 2021 | $11.22 | +23.8% |
| Dec 31, 2020 | $9.06 | N/A |
| Dec 31, 2019 | $9.07 | +8.9% |
| Dec 31, 2018 | $8.33 | +11.1% |
| Dec 31, 2017 | $7.50 | +13.3% |
| Dec 31, 2016 | $6.62 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,200 words across 11 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,162 | 11 | |
| 2026Q2 | Jun 30, 2026 | 7,250 | 11 | |
| 2026Q1 | Mar 31, 2026 | 7,965 | 10 | |
| 2025Q4 | Dec 31, 2025 | 6,778 | 12 | |
| 2025Q3 | Sep 30, 2025 | 6,277 | 9 | |
| 2025Q2 | Jun 30, 2025 | 7,849 | 11 | |
| 2025Q1 | Mar 31, 2025 | 8,941 | 14 | |
| 2024Q4 | Dec 31, 2024 | 8,968 | 13 |
2026Q3 Earnings Call
Opening remarks
Caspar Tudor Head of Investor Relations Thank you, Ryan, and good morning, everyone. Welcome to Waters Corporation's third quarter earnings call. Joining me today are Dr. Udit Batra, our President and Chief Executive Officer; and Amol Chaubal, our Senior Vice President and Chief Financial Officer. Before we begin, I will cover the cautionary language. In this conference call, we will make various forward-looking statements regarding future events or financial performance. We will provide guidance and commentary on possible future results and potential market and business conditions that may impact Waters over the fourth quarter of 2026, full year 2026 and 2027. These statements are only our present expectations and are subject to risks and uncertainties. Please see the risk factors in our SEC filings and the cautionary language included in this morning's earnings release. During today's call, we will refer to certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP measures are in our earnings release and the appendix of today's slide presentation. Unless stated otherwise, all organic revenue growth rates are presented on a constant currency basis and are in comparison to the third quarter of 2025. For acquired business revenue, unless stated otherwise, all growth rates are presented on an as-reported basis, covering the current period in comparison to the revenue as reported by BD for the prior year comparable period that predates Waters' ownership. Finally, we do not intend to update our guidance, predictions or projections except as part of a regularly scheduled earnings release or as otherwise required by law. On today's call, Udit will open with our key messages and business highlights. Amol will then walk through our financial results and updated guidance, and we will close with your questions. With that, it is my pleasure to turn the call over to Udit.
Udit Batra President and CEO Thank you, Caspar, and good morning, everyone. Let me start by thanking our colleagues around the globe who continue to work with rigor and speed to accelerate the benefits of pioneering science. We delivered another quarter of exceptional results with outstanding year-over-year and quarter-over-quarter momentum across our divisions. We grew double digits organically, extending our long-standing trend of delivering industry-leading results, with revenue stepping up approximately 5% from the second quarter. In our acquired businesses, we are well ahead of our expected pace of transformation and integration, with underlying growth building as our commercial actions, new product launches and revenue synergies take hold. New sources of growth are also amplifying our results as improving end markets and rising customer lab activity lift demand for our products in preclinical and downstream settings.
Frequently Asked Questions About WAT
When is Waters's next earnings date?
Waters's next earnings report is expected for Feb 8, 2027.
Did WAT beat earnings estimates last quarter?
Yes. Waters reported EPS of $4.10 for the quarter ended Sep 30, 2026, above the $3.99 estimate, a 2.76% surprise.
What EPS do analysts expect from WAT next quarter?
The consensus EPS estimate for Waters for the quarter ending Dec 31, 2026 is $4.71 from 22 analysts, with estimates from $4.53 to $5.00.
How often does WAT beat earnings estimates?
Waters beat the EPS estimate in each of the last 14 quarters, with an average surprise of +4.98%.
WAT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors